Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C
Pegylated interferon alpha (PEG-IFN-α) is widely used to treat chronic hepatitis C in combination with ribavirin. Many adverse effects of PEG-IFN-α, such as hematologic, psychologic, dermatologic, immunologic, and other abnormalities, have been reported, and some serious adverse events lead to PEG-I...
Main Authors: | June Seok Song, Joo Hyun Sohn, Jae Yoon Jeong, Ji-Hee Min, Won Seok Choi, One Zoong Kim, Ju Yeon Pyo |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2016-05-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2016.67.5.272 |
Similar Items
-
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)
by: Dae Won Jun, et al.
Published: (2018-01-01) -
Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience
by: Bojović Ksenija, et al.
Published: (2020-01-01) -
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
by: Juan José Urquijo, et al.
Published: (2013-01-01) -
Successful Antiviral and Antituberculosis Treatment With Pegylated Interferon-alfa and Ribavirin in a Chronic Hepatitis C Patient With Pulmonary Tuberculosis
by: Ming-Chao Tsai, et al.
Published: (2009-09-01) -
Lupus panniculitis: diagnostic difficulties
by: O. N. Egorova, et al.
Published: (2019-09-01)